Author:
Appel I M,Pinheiro J P V,den Boer M L,Lanvers C,Reniers N C M,Boos J,Pieters R
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference9 articles.
1. Asselin BL, Whitin JC, Coppola DJ, Bernal SD, Leavitt PR, Gelber RD et al. Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol 1993; 11: 1780–1786.
2. Boos J, Werber G, Ahlke E, Schulze-Westhof P, Nowak-Gottl U, Wurthwein G et al. Monitoring on asparaginase activity and asparaginase levels in children on different asparaginase preparations. Eur J Cancer 1996; 32A: 1544–1550.
3. Riccardi R, Holcenberg JS, Glaubiger DL, Wood JH, Poplack DG . L-Asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of Rhesus monkeys and humans. Cancer Res 1981; 41: 4554–4558.
4. Rizzari C, Zucchetti M, Conter V, Diomede L, Bruno A, Gavazzi L et al. L-Asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C or E. Coli L-asparaginase as first exposure. Ann Oncol 2000; 11: 189–193.
5. Müller HJ, Loning L, Horn A, Schwabe D, Gunkel M, Schrappe M et al. Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols. Br J Hematol 2000; 110: 379–384.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献